Bright Minds Biosciences
b'
Bright Minds Biosciences (OTCQB: BMBIF), is a biotechnology company focused on developing novel treatments for neuropsychiatry disorders, epilepsy and pain. Dr. Gideon Shapiro, Vice President of Discovery joins us to discuss the safety and efficacy of psychedelic treatments and how Bright Minds\\u2019 treatments differ from conventional medicine.
\\xa0
\\xa0\\u2028
'